DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Modis Navnirman Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·21 Oct 2026, 1:54 pm

Modis Navnirman

Modis Navnirman Limited has announced its schedule for an earnings conference call with analysts and investors. The meeting is set to take place on Monday, October 26th, 2026, at 1:00 PM IST. This event will cover the company's financial performance for the second quarter and the first half of fiscal year 2027.

For investors, this call provides a crucial opportunity to hear directly from management about the company's operational progress and future outlook. It serves as a platform to clarify any uncertainties and assess the firm's trajectory before the official financial results are released publicly.

Investors should watch for management's commentary on key business drivers, operational efficiency, and any guidance provided for the upcoming quarters. This information will be vital for evaluating the stock's potential in the near term.